WHO ICTRP trial
Study on the Application Value of Levosemindan Combined with Norepinephrine in…
ChiCTR2500111820 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500111820 |
|---|---|
| Public title | Study on the Application Value of Levosemindan Combined with Norepinephrine in Acute Myocardial Infarction Complicated by Cardiogenic Shock |
| Scientific title | Study on the Application Value of Levosemindan Combined with Norepinephrine in Acute Myocardial Infarction Complicated by Cardiogenic Shock |
| Primary sponsor | Fushun People's Hospital, Fushun |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | acute myocardial infarction |
| Interventions | Levosimendan combined with norepinephrine group:Levosimendan 12.5mg (5ml) was mixed with 5% glucose injection to 50ml (250ug/ml), and norepinephrine was added to 50ml (0.1 µ g/ml) by multiplying the actual body weight by 0.3 with 5% glucose… |
| Registration date | Nov 6, 2025 |
| Target size | Levosimendan combined with norepinephrine group:42;Norepinephrine group:42 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: